How to Land 2 Double-Digit Gains in One Day

You can gain a hell of a lot if you’re getting a steady stream of... [Energy and Capital Header] Practical Investment Analysis for the New Energy Economy How to Land 2 Double-Digit Gains in One Day Jeff Siegel | Apr 08, 2024 I was doing some research on Robinhood day trading when I learned something quite fascinating. Apparently, the real story about legendary outlaw Robin Hood is vastly different from the one I was told as a child. [Robinhood Day Trading] You know the story... He robbed from the rich and gave to the poor.  Folks portrayed him as a hero. But as I grew older, I understood that such a thing lends itself to the violent nature of socialism. So I rejected the concept of Robin Hood being a “hero.” Although it turns out, I was way off. Word is, Robin Hood didn’t steal from the rich. He stole from the king and his loyalists. And when he “gave to the poor,” he was actually returning their stolen goods. How can anyone not love that?!! As a liberty-minded advocate recently put it, what Robin Hood did was not an act of charity or redistribution of wealth. It was a rebellion against the state. Of course with this revelation, I can’t help but think about the very popular trading app, RobinHood (NASDAQ: HOOD).  Robinhood pitches itself as some sort of altruistic trading alternative designed to “democratize finance for all.”  A sort of modern-day “Robin Hood” designed to look out for the little guy. But is it true? Stuff like that always seems suspect to me. Especially in the case of this particular company.  [Mega-Billionaires Race to Capture “The Sun Beneath Our Feet”]( There’s a radical new power source that ultra-wealthy entrepreneurs like Buffet, Gates and Zuckerberg have their sights firmly set on. - It’s clean, renewable and astonishingly cheap... - Can deliver more energy per sq. foot than the surface of our sun... - And it could supply humanity’s energy needs for the next 91 billion years! Scientists refer to this newly-unlocked form of energy as “The Sun Beneath Our Feet”. But I simply call it “DeepSurge”. And if you invest in the obscure company behind it all before May 1st., I predict that you’ll make an incredible 59x ROI. [Click here to find out how.]( The Pros and Cons of Robinhood Day Trading You may recall a few years ago when the app froze all trading on GameStop (NYSE: GME). There were some questionable circumstances surrounding that decision. But make no mistake: what happened was not an example of “democratization” or “looking out for the little guy.” That being said, things have become a lot easier for amateur traders using the Robinhood day trading app. And that’s a good thing. How could I oppose a company that helps regular folks build wealth? Of course, to really make a lot of money, you need more than just the Robinhood day trading app. You need access to up-to-the-minute, and well-vetted intel. Because without it, you risk far more than what you can gain. And boy, you can gain a hell of a lot if you’re getting a steady stream of solid intel. Take, for instance, the intel I provided on a couple of biotech stocks regarding their progress on their FDA clinical trials. [These two companies in particular]( are running clinical trials on a new class of medications called EN-23. It’s actually one of the biggest breakthroughs medical science has seen in 50 years. Not just because it successfully treats mental health conditions such as depression, anxiety, PTSD and addiction. But also because it could help you extend your lifespan by up to 20 years. Now the FDA has a special designation for drugs that treat life-threatening conditions, as long as the evidence indicates those drugs demonstrate substantial improvement over currently available treatments. I knew these two companies met all the qualifications to meet this particular designation. It’s called “breakthrough status.” And for the past two years I’ve been monitoring their progress. When it became clear that both of these companies would qualify for “breakthrough status,” I put out a buy alert. Because if you know anything about biotech stocks, you know that this designation means the FDA will fast-track clinical trials. And nothing sends a biotech stock to the moon faster than a fast-tracked clinical trial. Nvidia Could Crash Soon Nvidia’s days are numbered... Because there’s a [new player in the AI market...]( A Californian company that developed a groundbreaking chip — one that outperforms Nvidia’s chips 100x. The U.S. Air Force is just one elite client that was allowed to use it early. But soon this chip will be available to the mainstream. And if you position yourself before it reaches the mass market, you could turn every $1 into $120... Just like early Nvidia investors did. Keith Kohl just published an urgent presentation on this unique opportunity. [Get the full story here while there’s still time.]( And that’s exactly what happened. The first was a stock called MindMed (NASDAQ: MNMD). It soared nearly 90% on the news that it was granted “breakthrough status” by the FDA. Check it out... [mnmd11] Then, just a few days later, it happened again. This time with a stock called Cybin (NYSE: CYBN). That one soared 37% in a matter of hours. [cybn] Now I don’t know if they used this intel and profited handsomely using the Robinhood day trading app. But no matter which trading platform they used, they made a lot of money. And here’s the best part... There are nearly a dozen more EN-23 companies that could also get “breakthrough status” designation this year. And I’ve written about a few of those stocks [here](. If you’re looking for a few easy scores as a day trader, you won’t do better than playing FDA approvals. And if you don’t believe it, just [look at the numbers for yourself.]( To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel [[follow basic]Check us out on YouTube!]( [[follow basic]@JeffSiegel on Twitter]( Jeff is the founder and managing editor of Green Chip Stocks. For more on Jeff, go to his editor's [page](. Want to hear more from Jeff? [Sign up to receive emails directly from him]( ranging from market commentaries to opportunities that he has his eye on. [Fb]( [Li]( [Tw]( This email was sent to {EMAIL}. You can manage your subscription and get our privacy policy [here](. Energy and Capital, Copyright © 3 East Read Street, Baltimore, MD 21202. Please note: It is not our intention to send email to anyone who doesn't want it. If you're not sure why you're getting this e-letter, or no longer wish to receive it, get more info [here]( including our privacy policy and information on how to manage your subscription. If you are interested in our other publications, please call our customer service team at [1-877-303-4529](tel:/18773034529).